An Interventional Study to Assess the Efficacy and Safety of Buprenorphine in Korean Patients With Spinal Disorders
Status:
Completed
Trial end date:
2013-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the pain reduction rate after 8 weeks treatment of
NORSPAN® from baseline.
And secondary purpose are: pain reduction rate after 4 weeks treatment from baseline(week 0)
the EQ-5D, the pain and sleep questionnaire, physician's overall satisfaction subject's
overall satisfaction, and safety